NCT00958997 - Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

May 31, 2012

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

18F-FP-DTBZ (18F-AV-133)

The subjects will receive a single IV bolus of approximately 10 mCi 18F-AV-133.(Injection will contain no more than 25 µg of non-radiolabeled 19F-AV-133).

BIOLOGICAL

Arginine-hydrochloride

A bolus injection of 5g of 10% arginine-hydrochloride will be given over a period of 1 minute.

Trial Locations (1)

06520

Yale University School of Medicine, PET Center, New Haven